Markets are also awaiting interest rate decisions from both the Bank of England and the European Central Bank today, with analysts expecting both to hold rates steady.

United Utilities is the standout performer in the FTSE 100, surging 10.7% after reporting significantly higher profit and revenue in fiscal 2026, lifting its dividend and guiding for revenues of £2.7 billion to £2.8 billion in fiscal 2027.

The water company also outlined plans for additional regional investment in water and wastewater infrastructure, which it estimates could support a further 4,000 jobs across its supply chain. Fellow water utility Severn Trent is up 5.7% in sympathy.

Rolls-Royce rounds out the top three risers at +5.2%, after the engineer maintained its 2026 guidance of £4.0 billion to £4.2 billion in underlying operating profit, with the chief executive noting a significant recovery in engine flying hours among Middle Eastern airlines.

Weir Group leads the fallers, dropping 7.6% despite a solid first-quarter update with orders up 4% and guidance reiterated, as investors reacted negatively to the announcement that long-serving CEO Jon Stanton will step down on 1 August 2026.

Whitbread is down 4.9% after it announced plans to cut around 3,800 jobs. The is part of the company’s five-year plan for cost savings and overhaul the group. DCC is the other significant faller so far in the session, down 4.7%.

The post FTSE 100 Gains as European Markets Remain Cautious; United Utilities Surges appeared first on AskTraders.com.

The UK homebuilder reported a solid jump in forward sales and improved pricing, though management flagged early signs of supply chain inflation tied to geopolitical tensions.

Sales: Private forward sales climbed 7% to £1.80 billion versus the prior year, underpinned by a 5% increase in private average selling prices to approximately £306,900. Total forward sales currently stand at £2.46 billion.

Profit & Margins: Management anticipates full-year profit before tax to align with market consensus, targeting between 12,000 and 12,500 home completions for 2026.

Cash & Balance Sheet: The group maintains a robust balance sheet and a highly disciplined approach to land acquisition, with total land holdings ticking up 1% to roughly 84,900 plots.

The sustained pricing power and resilient reservation rates provide a solid foundation for shareholder returns over the medium term. With over half of its 2026 private homes and nearly all housing association homes already secured, Persimmon’s cash generation outlook remains highly visible.

This revenue security, combined with a rigorously controlled cost base and a vertically integrated model, positions the firm well to defend margins, potentially supporting future dividend stability or targeted capital returns even as macroeconomic headwinds build.

Driver Breakdown Box

• Pricing Power: Private average selling prices rose 5%, offsetting static incentive levels of 4-5% and supporting top-line growth.
• Institutional Demand: The addition of 19 new institutional partners in the affordable and build-to-rent sectors over the past 12 months underscores the resilience of a diversified three-brand strategy.
• Operational Efficiency: Planning successes yielded 3,080 approved plots in Q1, ensuring the company remains on track to operate from at least 300 active outlets.

AskTraders Takeaway: Markets are rewarding Persimmon’s operational execution today, but the horizon is not entirely clear. The acknowledged softening of recent inquiries and rising mortgage rates present tangible risks.

Furthermore, higher energy costs filtering into the supply chain are expected to hit the bottom line in late 2026 and into 2027. Markets will closely monitor how effectively the company’s vertically integrated manufacturing capabilities can absorb these impending cost shocks.

CEO Dean Finch stated, “Persimmon has started the year well, building on our strong performance in 2025, with an improved private sales rate and an increase in average selling prices,” reinforcing the company’s focus on maintaining flexibility and rigorous cost control amid broader economic uncertainty.

Analyst Summary: Bull and Bear Cases

The post Persimmon Posts Strong Q1 Sales: Shares Gain Despite Inflation Warnings appeared first on AskTraders.com.

Shares plunged over 5% in early trading as the weight of immediate restructuring friction overshadowed long-term cash flow promises.

Headline Numbers

• Revenue: While immediate top-line guidance was overshadowed by restructuring plans, room growth targets stand firm at 96,000 in the UK and 18,000 in Germany by FY31, positioning the group to capture long-term market share.
• Profit & Margins: Core profit is projected to see a £275m incremental adjusted PBT contribution by FY31, translating to a substantial 500bps increase in Group ROCE.
• Cash & Balance Sheet: The net capex profile will shrink by over £1bn compared to the previous plan, with future growth funded by recycling £1.5bn of freehold real estate.

The strategic pivot is heavily geared toward unlocking capital returns over the medium term, with management forecasting £2bn in free cash flow available for dividends and share buybacks by FY31. However, the immediate cost of extending the Accelerating Growth Plan means Whitbread will pause its share buyback program in FY27. This near-term capital drought, combined with a £40m adjusted PBT hit expected during the restaurant transition phase, has clearly tested market patience and driven today’s aggressive sell-off.

Driver Breakdown Box

• F&B Restructuring & Job Cuts: The group is selling or converting over 200 branded restaurants into integrated hotel F&B offerings. This operational shift is driving the painful reduction of approximately 3,800 jobs but is expected to unlock higher-margin extension rooms and yield 15% to 20% returns on capital by FY31.
• Asset-Light Transition: Whitbread is shifting away from its historically heavy property ownership. Management plans to reduce freehold real estate from 50% to between 30% and 40% over time, drastically decreasing capital intensity without compromising the balance sheet.
• German Margin Expansion: Having finally reached profitability in Germany, the regional focus shifts to accelerating free cash flow. The pipeline aims to scale operations to 18,000 rooms, contributing an expected £65m in incremental adjusted PBT by the end of the five-year plan.

AskTraders Takeaway: The market’s 5% sell-off reflects a classic duration mismatch between management’s five-year vision and traders’ near-term earnings expectations. While the £2bn free cash flow target and property recycling strategy offer a compelling long-term value thesis, the FY27 buyback pause and restructuring costs provide immediate headwinds. Markets are currently pricing in the severe execution risk associated with a massive workforce reduction and the disposal of underperforming restaurant assets.

CEO Dominic Paul stated, “This plan will transform Whitbread into a higher-margin, higher-returning pure-play hotel business,” reinforcing the company’s focus on leveraging its Premier Inn brand to mitigate significant external cost increases in business rates and National Insurance.

Analyst Summary: Bull and Bear Cases

The post Whitbread Unveils Overhaul—Job Cuts and Near-Term Costs Push Shares Lower appeared first on AskTraders.com.

The aerospace and defense giant maintained its ambitious 2026 financial targets, demonstrating operational resilience and proactive mitigation against geopolitical supply chain headwinds in the Middle East.

Headline Numbers

• Revenue: Civil Aerospace large engine flying hours (EFH) reached 115% of 2019 levels in the first quarter, while Power Systems order intake surged 50% year-on-year.
• Profit & Margins: Underlying operating profit guidance for 2026 remains firmly anchored between £4.0 billion and £4.2 billion, driven by improved operational momentum and best-in-class cost-to-margin ratios.
• Cash & Balance Sheet: Free cash flow targets of £3.6 billion to £3.8 billion remain unchanged. The growing cash pile provided flexibility to repay a €750 million bond from free cash flow, prompting recent credit rating upgrades to A3 (Moody’s) and A- (Fitch).

The reaffirmed guidance and robust cash generation underscore a dramatically improved capital allocation profile. By completing over £750 million of the £2.5 billion 2026 tranche within its broader £7 billion to £9 billion share buyback program, Rolls-Royce is aggressively returning capital to shareholders.

This sustained repurchase activity, combined with a de-risked net cash balance sheet, signals strong internal confidence in long-term margin expansion.

Furthermore, the company’s ability to drive aftermarket service revenues without altering the large engine shop visit profile for 2026 and 2027 significantly enhances shareholder value and insulates the stock from broader macroeconomic volatility.

Driver Breakdown

• Civil Aerospace Momentum: Large engine original equipment (OE) deliveries grew 18% in the first quarter, while aircraft-on-ground (AOG) metrics fell to industry-leading single digits. Notably, Trent XWB engine flying hours in the Middle East have fully recovered to pre-conflict levels.
• Power Systems Surge: Driven by power generation demands for data centers and governmental contracts, the division’s order backlog expanded to £7.3 billion following a record-breaking March.
• Defence and SMR Execution: Defence OE deliveries rose by more than 20%, supported by key structural tailwinds and program wins. Simultaneously, new Small Modular Reactor (SMR) contracts in the UK and Czech Republic have entered the execution phase and are slated to generate revenues and profits this year.

AskTraders Takeaway: Markets are pricing in the success of Rolls-Royce’s internal efficiency initiatives. The ability to fully mitigate supply chain disruptions tied to the Middle East conflict while simultaneously expanding widebody engine margins provides a clear catalyst for near-term momentum and continued institutional accumulation.

CEO Tufan Erginbilgic stated, “We have had a strong start to the year driven by our transformation and self-help, as we continue to further expand the earnings, cash, and growth potential of the business,” reinforcing the company’s focus on building a resilient, agile enterprise.

Analyst Summary: Bull and Bear Cases

The post Rolls-Royce Shares Rally as Strategy Cements 2026 Guidance appeared first on AskTraders.com.

The consumer goods giant demonstrated broad-based momentum, particularly across emerging markets, while advancing its strategic pivot toward becoming a pure-play Health, Beauty, and Personal Care (HPC) company.

Revenue: Underlying sales growth (USG) hit 3.8% against a reported turnover of €12.6 billion. While total turnover dropped 3.3% due to a sharp 7.7% currency headwind and net acquisitions/disposals, the core USG signals resilient consumer demand. At this growth rate, they are comfortably tracking toward the bottom end of their 4% to 6% multi-year target.

Profit & Margins: The company anticipates a modest improvement in underlying operating margin for the full year 2026, building on the 20.0% achieved in 2025. This margin expansion is heavily bolstered by a 2024 productivity programme that has already delivered €750 million in savings, running well ahead of its €800 million year-end target.

Cash & Balance Sheet: Capital allocation remains highly active, supported by an ongoing portfolio reshape. The planned combination of the Foods division with McCormick is set to unlock significant value. Cash receipts from upcoming strategic moves are expected to support an impressive €6 billion in share buybacks between 2026 and 2029.

Markets reacted positively to management’s aggressive return of capital. A €1.5 billion share buyback programme commences today, targeting completion by early July 2026. Furthermore, the quarterly interim dividend was raised by 3.0% year-over-year to €0.4664 per share. This underlines the board’s confidence in near-term cash generation despite macroeconomic uncertainties and currency volatility.

Driver Breakdown

• Power Brands Outperformance: The company’s top-tier brands led the charge with a 5.0% USG and an impressive 4.0% volume growth, proving that premium innovation in categories like Dove and Vaseline continues to capture market share.
• Emerging Market Muscle: Emerging markets delivered a 5.7% USG, anchored by a robust 7% expansion in India and a sequential volume recovery in Latin America.
• Home Care Acceleration: The Home Care division was the standout segment, posting a 6.1% USG entirely driven by a 6.2% volume surge across key emerging geographies, offsetting softer European markets.

AskTraders Takeaway: The structural overhaul is progressing smoothly. The McCormick combination removes the slower-growing Foods segment, paving the way for a structurally higher growth profile in the HPC space. Markets are pricing in the $600 million in expected annual run-rate cost synergies from this deal, providing a clear catalyst for medium-term margin expansion.

CEO Fernando Fernandez stated, ‘We have started the year well with volume-led growth driven by our Power Brands and a positive performance across all Business Groups,’ reinforcing the company’s focus on building a simpler, sharper Unilever with a brand portfolio fit for the future.

Analyst Summary: Bull and Bear Cases

The post Unilever Shares Edge Higher as Sales Rise appeared first on AskTraders.com.

The selloff is seemingly at odds with the tone of analyst commentary, with both Shore Capital and Edison Research remaining firmly constructive on the stock following the update.

Shore Capital highlighted continued rental growth momentum, noting that 199 completed rent reviews in the quarter generated an additional £3 million of income, representing a roughly 6% uplift on previous contracted rents and an annualized increase of 3.4%, ahead of the 3.2% delivered in fiscal 2025.

The broker also pointed to encouraging progress on deleveraging, with the company advancing both its existing USS joint venture, where £103 million of disposals are under offer, and a new strategic vehicle for its £700 million private hospital portfolio, with four offers under evaluation and expected to conclude by summer 2026.

Shore Capital flagged a prospective dividend yield of 7.8% for fiscal 2026, calling PHP shares “a highly attractive opportunity for investors offering among the best risk-adjusted, total returns profiles in the sector.”

Edison echoed that view, noting that 87% of the £9 million targeted cost synergies from the Assura acquisition have already been delivered, with integration on track to complete by end of June, ahead of schedule.

Edison projects fully covered dividends per share of 7.3 pence for fiscal 2026, representing the 30th consecutive year of dividend growth, and flagged the prospective 7.8% yield as comparing favorably against the 10-year UK gilt yield of 5.0%.

Both firms see the portfolio’s roughly 85% government-backed income base and strong demographic tailwinds as underpinning the investment case.

The post Primary Health Properties Shares Dip After Trading Update – Analysts Stay Bullish appeared first on AskTraders.com.

Revenue: Total Q1 sales reached £7.6 billion, representing a 5% increase at constant exchange rates (CER). At this growth rate, the top line is tracking comfortably within the firm’s projected 3% to 5% full-year target, despite adverse sterling movements against the dollar.

Profit & Margins: Core operating profit grew 10% CER to £2.65 billion, translating to a core operating margin expansion of 1.8 percentage points to 34.7%. This profitability beat was fuelled by a favourable regional product mix, higher royalty income, and disciplined SG&A spending.

Cash & Balance Sheet: Cash generated from operations stood at a healthy £1.4 billion, yielding £800 million in free cash flow. This gives the pharmaceutical giant ample balance sheet flexibility to continue R&D investments and pursue bolt-on pipeline acquisitions.

Management remains highly committed to returning capital, declaring a Q1 dividend of 17p per share with a clear path toward a 70p full-year payout. Furthermore, the company has already executed £1.7 billion of its £2 billion share buyback programme initiated last year.

Driver Breakdown Box

• Specialty Medicines Surge: The segment jumped 14% to £3.2 billion, heavily lifted by Oncology sales (+28%) and Respiratory, Immunology & Inflammation (+16%).
• Vaccine Resilience: Vaccines posted a 4% gain to £2.1 billion, anchored by a massive £1.0 billion contribution from Shingrix (+20%), which successfully offset a steep 18% decline in Arexvy.
• Tariff Relief: A definitive agreement with the US Government shields GSK and ViiV Healthcare from Section 232 tariffs through January 2029, removing a significant overhang on future gross margins.

AskTraders Takeaway: So what does this mean for the stock? The 1.9% dip in shares likely reflects broader macroeconomic positioning and minor market concerns over the 6% contraction in General Medicines, rather than a fundamental flaw in the Q1 print. The reaffirmed guidance highlights underlying operational stability, making the post-earnings pullback a potential area of interest for value-oriented participants.

Watch the R&D pipeline progression into the second half of the year. With regulatory filings accepted for bepirovirsen—a potential functional cure for chronic hepatitis B—and updated Phase III plans for oncology ADCs, clinical execution could serve as a major upside catalyst.

CEO Luke Miels stated, “GSK has made a strong start to 2026, with good performance from our key growth drivers,” reinforcing the company’s focus on execution and accelerating R&D through strategic acquisitions like ozureprubart for food allergies.

Analyst Summary: Bull and Bear Cases

The post GSK Posts Solid Q1 Sales and Reaffirms 2026 Guidance appeared first on AskTraders.com.

Revenue: Group like-for-like sales expanded by a robust 4.8%, demonstrating resilience against a sluggish broader retail backdrop. This top-line momentum was anchored by a 4.1% rise in Retail LfL sales and a standout 5.8% increase in Autocentres, excluding the Avayler software business.

Profit & Margins: FY26 underlying PBT is now projected to hit the upper bound of the £36.0 million to £41.2 million consensus range. This profitability upgrade is directly attributed to sustained gross margin expansion and disciplined, well-managed operational costs throughout the fiscal year.

Cash & Balance Sheet: The Group remains highly cash generative, successfully closing the financial period to April 3 in a definitive net cash position.

Transitioning to a net cash position provides Halfords with significant balance sheet flexibility. For markets, this signals a fundamentally de-risked financial profile.

The robust liquidity not only fortifies the company against broader macroeconomic uncertainties but also paves the way for potential shareholder value enhancements. This could materialize through progressive dividend distributions or targeted capital expenditures aimed at expanding the high-margin Autocentres division.

Driver Breakdown

• Cycling Resurgence: Retail Cycling LfL sales jumped 6.4%, indicating a strong recovery and resilient consumer demand in a segment that has historically faced post-pandemic volatility.
• Service Sector Momentum: The garage services arm delivered a 5.8% LfL growth, reinforcing the strategic pivot toward non-discretionary, service-based revenues that offer higher margins and recurring customer touchpoints.
• Proactive Cost Hedging: The majority of FY27 energy costs, foreign exchange requirements, and freight rates are already contracted in advance. This foresight severely limits near-term margin erosion from global supply chain shocks.

The 10% upward repricing reflects market relief over both the FY26 profit beat and the highly confident FY27 outlook. While conflict in the Middle East continues to create an uncertain macroeconomic backdrop, Halfords confirmed that trading through March and April remained strictly in line with expectations.

By successfully hedging major input costs, the retailer has effectively insulated its bottom line, allowing management to comfortably back FY27 underlying PBT consensus estimates of £42.0 million to £48.6 million.

CEO Henry Birch stated, “I am pleased to see the positive results that are starting to materialise from the ‘optimise’ phase of our ‘Fit for the Future’ strategy as we focus on driving operational excellence and strengthening our foundations for future growth,” reinforcing the company’s focus on internal efficiencies and thanking the 12,500 staff members who executed the vision.

The post Halfords Shares Surge 10% as FY26 Profit Tracks Toward Upper End of Expectations appeared first on AskTraders.com.

While North America finally returned to growth, the broader respiratory drag has prompted markets to adopt a cautious stance, sending shares slightly lower despite management reiterating full-year guidance.

Reported revenue came in flat at £2.86 billion, translating to a mere 0.1% reported growth year-over-year. Organic growth of 2.2% was driven entirely by a 2.4% pricing increase, which barely offset a slight 0.2% volume contraction.

While specific Q1 profit figures were omitted from the trading update, core supply chain productivity initiatives continue to drive gross margin expansion. This operational efficiency supports the reiterated target of high-single-digit adjusted operating profit growth at constant currency for the fiscal year.

Capital allocation remains highly disciplined, with the company progressing steadily on its £500 million share buyback program for 2026.

Haleon’s commitment to shareholder returns remains a bright spot amidst the top-line deceleration. The consumer healthcare giant has already completed approximately 36% of its £500 million share buyback allocation for the year.

This ongoing repurchasing activity provides a vital floor for the stock, signaling management’s confidence in cash generation and long-term value creation even as external macroeconomic headwinds and volume pressures persist.

Driver Breakdown Box:

• Respiratory Drag: A notably weak cold and flu season shaved an estimated 130 basis points off total organic growth, pushing overall Respiratory Health category revenues down 3.4% for the quarter.
• Oral Health Outperformance: Sensodyne and parodontax continue to command strong pricing power and market share. Continuous innovation rollouts across the clinical platform drove an impressive 8.3% organic growth in the Oral Health division.
• North American Recovery: Despite the respiratory headwinds, the critical North American market returned to positive territory with 1.0% organic revenue growth, indicating that broader brand activations and strategic growth initiatives are successfully gaining traction.

AskTraders Takeaway:

The Q1 print paints a picture of a resilient, diversified portfolio masking localized seasonal weakness. Markets are currently fixating on the slight volume contraction and the respiratory segment’s drag on the top line. However, underlying operational leverage remains firmly intact. With gross margins expanding and the foreign exchange translation impact now expected to be broadly neutral for the year, profitability metrics are shielded. Volatility may persist in the near term as markets digest the sluggish volumes, but the reiterated 3-5% full-year organic growth target suggests management anticipates a steeper acceleration in the back half of the year.

CEO Brian McNamara stated, “We delivered a competitive performance in a challenging market, with North America returning to growth and Oral Health again performing strongly… tempered by a weak cold and flu season,” reinforcing the company’s focus on productivity initiatives and geographic expansion to drive agility.

Eyes On: Watch margin expansion closely in the upcoming quarters—if supply chain productivity continues to outpace inflation, it could fuel a sustained rally regardless of seasonal top-line fluctuations.

The post Haleon Shares Edge Lower as Weak Cold and Flu Season Weighs on Q1 Sales appeared first on AskTraders.com.

Despite the solid fundamental performance and resilient credit metrics, markets reacted with mild skepticism, sending shares down approximately 1.2% in the early part of the session.

Underlying net interest income hit £3.6 billion, up 8% year-on-year. At this growth rate, the bank is comfortably tracking toward its reiterated 2026 guidance of greater than £14.9 billion in net interest income, supported by underlying other income of £1.6 billion.

Statutory profit before tax jumped to £2.0 billion from £1.5 billion a year ago. Core profitability metrics were exceptional, translating to a return on tangible equity of 17.0% and an improved cost:income ratio of 51.9%.

The CET1 ratio stands at a healthy 13.4% after ordinary dividend accruals, giving the bank ample flexibility for future distributions. Tangible net assets per share expanded to 57.9 pence, up 0.9 pence for the quarter.

The strong capital generation of 41 basis points highlights Lloyds’ ongoing capacity to drive shareholder value. The bank remains structurally positioned to support ongoing dividends and share buybacks, as evidenced by management’s stated goal to optimize the CET1 ratio down to approximately 13.0%.

However, a slight £0.6 billion dip in customer deposits to £495.9 billion, alongside a 10% jump in operating lease depreciation to £389 million due to declining used car prices, may be giving markets a reason to trim positions. This underlying friction likely explains the current 1.2% slide in the share price despite the top-line beat.

Driver Breakdown

• Net Interest Margin Expansion: NIM expanded by 14 basis points year-on-year to 3.17%, fueled by strong structural hedge income and targeted franchise volume growth.
• Strict Cost Discipline: Operating costs declined by 3% to £2.5 billion. Lower severance expenses and structural cost savings successfully offset broader inflationary pressures and business growth investments.
• Resilient Asset Quality: The underlying impairment charge of £295 million resulted in an asset quality ratio of just 25 basis points. This reflects a stable credit environment, even after factoring in a £101 million net charge from updated multiple economic scenarios.

CEO Charlie Nunn stated, ‘We are confident in our delivery for the year ahead and reiterate our guidance for 2026. We look forward to presenting our new strategy alongside the half-year results.’, reinforcing the company’s strategic momentum and commitment to supporting UK households.

The post Lloyds Banking Group Posts Strong Q1 Profit, But Shares Dip—Here’s Why You Should Care appeared first on AskTraders.com.

Shares opened lower on cautious forward-looking commentary regarding the Middle East, but markets quickly digested the strong balance sheet, sending the stock up over 1% in mid-morning trading.

A burst of volume post-print suggests early morning short-covering could extend into tomorrow’s session, as the initial knee-jerk reaction to geopolitical commentary was swiftly bought up by value-seeking market participants.

Profit & Margins: The group expects to report an operating profit between £435m and £440m, stepping down slightly from FY25’s £446.5m. This figure comfortably absorbs £11m in promotional and resourcing startup costs tied to the highly anticipated London Gatwick base launch.

Cash & Balance Sheet: Total cash stands at a formidable £3.3bn with net cash at £2.0bn. The airline also retains access to an undrawn £500m Revolving Credit Facility, providing robust liquidity to navigate cyclical headwinds.

The fortress balance sheet is doing exactly what it was designed to do—insulating the company from short-term macro volatility while actively rewarding equity holders. Jet2 successfully returned £363.0m of capital to shareholders during the fiscal year.

That disciplined capital allocation, combined with sustained investments in future growth, signals a management team highly focused on long-term shareholder value creation rather than just weather-proofing the current quarter.

Driver Breakdown

• Gatwick Expansion: The operational launch at London Gatwick marks Jet2’s entry into the UK’s biggest holiday airport, bringing 90% of the British public within a 90-minute drive of a Jet2 base.
• Capacity & Bookings: Summer 2026 on-sale capacity is up 7.7% to 19.9m seats, with booked-to-date passengers rising 6.2% across both package holidays and flight-only segments.
• Cost Certainty: The group boasts a highly defensive hedged position, locking in 87% of its summer requirement with jet fuel swaps at an average price of $707 per metric tonne.

AskTraders Takeaway: Markets initially balked at the disclosure that geopolitical uncertainty in the Middle East is pushing the booking profile increasingly close to departure dates.

Watch the combined average load factor in Q1; maintaining parity with the prior year despite late bookings will be critical to sustaining this equity rally. Fortunately, short-term volatility is largely mitigated by the airline’s aggressive fuel hedging and expansive £2.0bn net cash buffer, allowing them to remain fully committed to attractive pricing without sacrificing margins.

CEO Steve Heapy stated, “FY26 was another strong year for Jet2, topped off by the successful launch of operations at London Gatwick which is performing ahead of our initial expectations with over 0.4m passengers booked for the summer season,” reinforcing the company’s customer-focused and service-led business model.

Analyst Summary: Bull and Bear Cases

The post Jet2 Hits FY26 Targets Amid Geopolitical Uncertainty—Here’s Why Markets Are Buying The Dip appeared first on AskTraders.com.

The moving average picture is notably split. Of the key moving averages tracked, eight are currently issuing sell signals against just five buys, with one neutral reading, suggesting a bearish skew driven predominantly by the shorter-duration averages crossing into negative territory.

This suggests recent price weakness has been sufficient to drag near-term trend indicators lower, even as the longer-dated moving averages, which carry the memory of the index’s stronger performance over prior months, continue to point upward.

The divergence between short and long-term averages is a hallmark of a market in transition, where momentum has faded but the broader structural trend has not yet broken down.

Oscillators offer little clarity. Of the eleven tracked, seven are reading neutral, while two are signalling sell and two signal buy, a distribution that reflects an index neither meaningfully overbought nor oversold.

The absence of a strong directional lean from momentum indicators suggests buying pressure and selling pressure are broadly in balance, with no clear catalyst yet to break the deadlock.

The overall technical summary sits at neutral, with ten sell signals, eight neutral and seven buys across all indicators combined, a picture of an index waiting for a decisive push in either direction.

The post FTSE 100 Caught in Technical Tug-of-War as Mixed Signals Point to Near-Term Uncertainty appeared first on AskTraders.com.